fibrinogen has been researched along with Muscle Weakness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, CX; Luo, F; Wu, B; Zhang, N | 1 |
| Allinder, M; Bolton, CE; Calverley, PMA; Cheriyan, J; Cockcroft, JR; Fisk, M; Forman, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; Marchong, M; McEniery, CM; Miller, BE; Mohan, D; Nagarajan, S; Polkey, MI; Tal-Singer, R; Wilkinson, IB | 1 |
2 other study(ies) available for fibrinogen and Muscle Weakness
| Article | Year |
|---|---|
[Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19)].
Topics: Betacoronavirus; Blood Cell Count; C-Reactive Protein; China; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Family Health; Fever; Fibrinogen; Humans; L-Lactate Dehydrogenase; Muscle Weakness; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tomography, X-Ray Computed; Travel | 2020 |
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
Topics: Aged; Aorta; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Muscle Contraction; Muscle Weakness; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Vascular Stiffness | 2018 |